article · International Journal of Drug Delivery Technology
Background: Multiple sclerosis represents a complex neurological disorder driven by immune-mediated processes within the central nervous system. Interleukin-7 receptor alpha (IL7Rα) and Brain-Derived Neurotrophic Factor (BDNF) may be considered integral to its pathophysiology, making their genetic variants prime candidates for investigation. Objective: To determine the relationship between the IL7Rα (rs6897932) and BDNF (rs6265) gene variants and the susceptibility to MS. Methods: This case-control study involving 79 MS patients, alongside 79 healthy controls matched for age and sex. Single nucleotide variants for IL7Rα (rs6897932) and BDNF (rs6265) were identified through TaqMan Real-Time PCR genotyping assays. Results: The frequency of the CC genotype and C allele of both IL7Rα (rs6897932) and BDNF (rs6265) gene variants was higher in MS patients compared to controls. However, this difference did not reach clinical significance in terms of genotype distribution and allelic discrimination for IL7Rα. In contrast, there was a significant difference in genotype distribution for BDNF (p = 0.02). Additionally, neither genetic variant showed any association with clinical parameters such as the EDSS, age of onset, or annual relapse rate. Conclusion: The rs6265 C/C genotype was significantly more common in MS, indicating a potential involvement of BDNF-mediated neuroimmune mechanisms in MS susceptibility in this population.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.25258/ijddt.16.49s.73
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.